Proteoforms in 2016 Savaryn, Toby et al., Proteomics, Human PBMC, Sample Set 2

PFR Accession Description Modifications Length Confidence
16451 Q93079 Histone H2B type 1-H Acetylation@16, Acetylation@17, Acetylation@21, Acetylation@24 125
16444 Q71DI3 Histone H3.2 N-Terminal Acetylation, L-allysine@5, Dimethylation@9 135
16438 P06702 Protein S100-A9 N-Terminal Acetylation 114
16429 Q96KK5 Histone H2A type 1-H N-Terminal Acetylation, Phosphorylation@2, Dimethylation@4, Acetylation@6 128
16426 P62805 Histone H4 N-Terminal Acetylation, Dimethylation@4 102
16424 P69905 Hemoglobin subunit alpha 31
16421 P06576 ATP synthase subunit beta, mitochondrial 160
16406 P51397 Death-associated protein 1 86
16405 P51397 Death-associated protein 1 31
16403 Q16695 Histone H3.1t 48
16398 P58876 Histone H2B type 1-D Phosphorylation@15, Acetylation@21, Acetylation@24 125
16390 P62805 Histone H4 34
16389 Q71DI3 Histone H3.2 Monomethylation@5, Dimethylation@9 135
16376 Q71DI3 Histone H3.2 Dimethylation@3, L-allysine@5, Dimethylation@9 135
16375 O43768-1 Alpha-endosulfine N-Terminal Acetylation, Phosphorylation@2 120
16372 P62750 60S ribosomal protein L23a Trimethylation@2, Deamidation@41 155
16368 P81605-1 Dermcidin 42
16361 P62158 Calmodulin N-Terminal Acetylation, Acetylation@95 148
16360 Q9UII2-1 ATPase inhibitor, mitochondrial N-Terminal Acetylation 81
16335 P62805 Histone H4 Acetylation@9, Acetylation@13, E64Q 102